FRONTIER MEDICINES
Dead / Abandoned — Abandoned — no statement of use filed (as of 12 May 2025)
What this means for you
This application is over — abandoned 12 May 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90112740
- Mark type
- Stylized text
- Filed
- 13 Aug 2020
- Published for opposition
- 08 Feb 2022
- Abandoned
- 12 May 2025
- Attorney of record
- Muzamil Huq
Goods and services
- Class 005 — Pharmaceuticals: Small molecule pharmaceuticals for the treatment of heart disease, blood pressure, Alzheimer's disease, arthritis, diabetes, obesity, mitochondrial disease, autoimmune diseases, hypertension, inflammatory bowel disease, amyotrophic lateral sclerosis, neurological diseases, allergies and asthma, hepatic disease, pulmonary disease, renal disease, and infectious diseases in humans
Owner
- Frontier Medicines Corporation, South San Francisco, CA, US
- Frontier Medicines Corporation, South San Francisco, CA, US
Prosecution history
- 12 May 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 12 May 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 25 Feb 2025 — CORRECTED NOA E-MAILED
- 21 Aug 2024 — CORRECTED NOA E-MAILED
- 21 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Aug 2024 — SOU EXTENSION 5 GRANTED
- 17 May 2024 — SOU EXTENSION 5 FILED
- 21 Aug 2024 — DIVISIONAL PROCESSING COMPLETE
- 17 May 2024 — DIVISIONAL REQUEST RECEIVED
- 18 May 2024 — TEAS REQUEST TO DIVIDE RECEIVED
- 24 Jun 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 May 2024 — SOU TEAS EXTENSION RECEIVED
- 16 Apr 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 16 Apr 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 16 Apr 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED